10-decarboxymethylaclacinomycin A
Star0
Identification
- Generic Name
- 10-decarboxymethylaclacinomycin A
- DrugBank Accession Number
- DB01806
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 753.8318
Monoisotopic: 753.336040723 - Chemical Formula
- C40H51NO13
- Synonyms
- DCMAA
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism URdmC Not Available Streptomyces purpurascens - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- OXPCRXLITLBLEY-ZVNFQBCFSA-N
- InChI
- InChI=1S/C40H51NO13/c1-7-40(48)16-21-13-23-34(37(47)33-22(35(23)45)9-8-10-26(33)43)36(46)32(21)28(17-40)52-30-14-24(41(5)6)38(19(3)50-30)54-31-15-27(44)39(20(4)51-31)53-29-12-11-25(42)18(2)49-29/h8-10,13,18-20,24,27-31,38-39,43-44,46,48H,7,11-12,14-17H2,1-6H3/t18-,19+,20+,24+,27+,28+,29+,30+,31-,38-,39+,40+/m1/s1
- IUPAC Name
- (8S,10S)-10-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-{[(2R,4S,5R,6S)-4-hydroxy-6-methyl-5-{[(2R,6R)-6-methyl-5-oxooxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-8-ethyl-1,8,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- SMILES
- CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@@H]3C[C@H](O)[C@@H](O[C@H]4CCC(=O)[C@@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2C1)C(=O)C1=C(C(O)=CC=C1)C3=O
References
- General References
- Not Available
- External Links
- PubChem Compound
- 49866627
- PubChem Substance
- 46506454
- ChemSpider
- 25057101
- ZINC
- ZINC000098208657
- PDBe Ligand
- AKA
- PDB Entries
- 1q0z
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.134 mg/mL ALOGPS logP 2.94 ALOGPS logP 4.23 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 7.63 Chemaxon pKa (Strongest Basic) 9.06 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 14 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 190.75 Å2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 193.01 m3·mol-1 Chemaxon Polarizability 81.18 Å3 Chemaxon Number of Rings 7 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.5968 Blood Brain Barrier - 0.9659 Caco-2 permeable - 0.6039 P-glycoprotein substrate Substrate 0.8372 P-glycoprotein inhibitor I Inhibitor 0.7414 P-glycoprotein inhibitor II Inhibitor 0.6315 Renal organic cation transporter Non-inhibitor 0.8452 CYP450 2C9 substrate Non-substrate 0.7314 CYP450 2D6 substrate Non-substrate 0.8561 CYP450 3A4 substrate Substrate 0.6982 CYP450 1A2 substrate Non-inhibitor 0.6122 CYP450 2C9 inhibitor Non-inhibitor 0.8538 CYP450 2D6 inhibitor Non-inhibitor 0.8179 CYP450 2C19 inhibitor Non-inhibitor 0.8278 CYP450 3A4 inhibitor Non-inhibitor 0.7552 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8501 Ames test AMES toxic 0.9107 Carcinogenicity Non-carcinogens 0.9095 Biodegradation Not ready biodegradable 0.9968 Rat acute toxicity 4.1111 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9451 hERG inhibition (predictor II) Non-inhibitor 0.7751
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 246.62062 predictedDeepCCS 1.0 (2019) [M+H]+ 248.47978 predictedDeepCCS 1.0 (2019) [M+Na]+ 254.6733 predictedDeepCCS 1.0 (2019)
Targets
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52